CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Sedation,RASS Targeted plus BIS Monitoring +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00469482
NCT00469482N/ACompleted

A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients

Vanderbilt University Medical Center·interventional·Posted May 4, 2007·Updated Mar 8, 2018

In Brief

A clinical study evaluating Sedation,RASS Targeted plus BIS Monitoring and Sedation, RASS Targeted for Delirium and 2 related conditions. Completed, enrolled 28 participants across 1 site.

Detailed Summary

A combined strategy of Richmond Agitation and Sedation Scale (RASS) clinical targeting plus bispectral index (BIS) guided sedation in mechanically ventilated, critically ill patients will decrease time on mechanical ventilation, decrease the duration of intensive care unit (ICU) delirium and coma, and will improve subacute neurocognitive function when compared to sedation guided by RASS targeting alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMedtronic - MITG

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 4, 2007
Enrollment StartJun 1, 2007
Primary CompletionOct 1, 2008
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.2 years ago

Interventions

Sedation,RASS Targeted plus BIS Monitoringother

Providing patient sedation utilizing standard of care methods (RASS) plus BIS monitoring

Sedation, RASS Targetedother

Patient sedation utilizing standard of care methods (RASS targeted)